The third meeting of the Shanghai New Council was held, and Singapore enterprises are optimistic about the future of Shanghai

"Investing in Shanghai depends on the next five or ten years, and we are optimistic about the future here." CapitaLand China's Deputy Chief Executive Officer, Mr Yeung Chin Fu, said this on the eve of the third meeting of the Shanghai-Singapore Comprehensive Partnership Council.

On December 16, the third meeting of the Shanghai-Singapore Comprehensive Cooperation Council was held by video link, and the relevant departments, institutions and enterprises in Shanghai and Singapore signed memorandums of cooperation in the fields of scientific and technological innovation, finance, economy and trade commerce, and people-to-people exchanges. The two sides said that they should jointly promote the continuous improvement and upgrading of cooperation and exchanges between the two places, and jointly write a new chapter in Shanghai-Singapore all-round cooperation.

On 24 May 2019, the first meeting of the Shanghai-Singapore Comprehensive Cooperation Council was held in Shanghai, and five memorandums of cooperation were signed by government departments, arbitration institutions, financial institutions and enterprises of the two places. Since then, the all-round cooperation between Singapore and Shanghai has continued to strengthen.

CapitaLand entered China in 1994, one of the Group's core markets. Since then, CapitaLand has operated and managed more than 200 projects in more than 40 cities in China.

Raffles City, People's Square, invested by CapitaLand Singapore and opened in 2003. Courtesy of respondents

"Shanghai is the city with the most complete product line and the only city that brings together all of CapitaLand's formats." According to Yang Qinfu, Shanghai is one of the first cities for CapitaLand to enter China, as well as the headquarters and core business city of CapitaLand in China. At present, CapitaLand manages nearly 50 projects in Shanghai, covering residential, office buildings, shopping malls, commercial complexes, serviced apartments, as well as new economy assets (including industrial parks, logistics and data centers).

"CapitaLand's entry into Shanghai is equivalent to building a bridge for Singaporean enterprises to enter China, and now some of the Singapore brands that are stationed in Raffles City are following capitaland in this mall, and we hope to maintain this bridge between Singapore and China, and also lead Chinese brands to Singapore in the future." Yang Qinfu said that he is more looking forward to the convening of the Shanghai New Council to bring some new cooperation projects and open up new investment ideas, "Many Singaporean brands want to enter the Chinese market, and Shanghai is the first choice." We would also be happy to get involved if there are new projects. ”

In addition to CapitaLand, Which is deeply rooted in China, Raffles Healthcare Singapore has also chosen to land its flagship hospital in Shanghai.

Raffles Hospital Shanghai is a wholly-owned medical institution established by Raffles Medical Centre (Hong Kong) Limited (a wholly owned subsidiary of Raffles Healthcare Group in Singapore) in the form of a wholly-owned medical institution located in the Foreshore of the World Expo, and began trial operation on 26 July this year.

As the only fully foreign-funded general hospital in Shanghai, in the view of Dr. Xie Fengcai, Vice President of Raffles Healthcare Greater China, Shanghai Raffles Hospital can provide local residents with high-quality clinical technology and services while creating a special department, integrating the highlights of singapore's family general practitioner clinic and China's emergency department.

"From January 1 next year, we will open a 24-hour emergency department, operating room, and inpatient department, which will be opened step by step and in stages." Xie Fengcai said, "The preliminary construction and opening stages, including the acquisition of the Medical Institution Practice Permit, are inseparable from the support and guidance of the Shanghai Municipal Government, the Pudong New Area Government and the Health Commission, from the process of handling the work to the pre-opening approval, their help makes us full of confidence in doing this." In the future, we also hope to expand more opportunities in China, and we see such possibilities. ”

While established companies have chosen to enter Shanghai, more "rookies" have come to China through cross-border accelerated incubation projects.

At the first meeting of the Shanghai-Singapore Comprehensive Cooperation Council in May 2019, XNode Infinity and Enterprise Singapore signed a Memorandum of Understanding (MOU) on facilitating interaction between the China-Singapore Entrepreneurship and Innovation Ecosystem.

According to the Mouve, the two sides will organize and establish a Sino-Singapore innovation landing base in China to help Singaporean enterprises (including start-ups, smes and large enterprises) connect the Chinese business circle and the entrepreneurial innovation ecosystem, and provide professional localization services for Singaporean start-ups to enter the Chinese market.

In the same year, XNode Chuangji Infinity officially set up an overseas innovation base in Singapore to open a two-way cross-border accelerated incubation service, and more and more Singapore entrepreneurial teams came to China through cross-border accelerated incubation projects.

"We mainly provide accelerated incubation services to help Singaporean small and medium-sized technology companies enter the Chinese market, especially in the Yangtze River Delta market, and Shanghai plays the role of a gateway and first stop." Zhou Wei, founder and CEO of XNode Infinity, introduced it this way.

According to the data, as of 2021, XNode Creators Infinity has accelerated the entry of 30 Singaporean technology start-ups into China, of which 20 have landed in Shanghai.

One of the most typical examples is Neouro, a Singaporean cranial neurotechnology company that has landed through the Singapore Cross-border Entrepreneurship Acceleration Project. It is reported that the company's technology mainly serves children's ADHD and Alzheimer's disease, exploring solutions for brain-computer combination. At present, it has signed a cooperation agreement with Shanghai Enterprise Weishida Clinic to cooperate in the research and development of attention training system for children with ADHD and put it into the market, and was successfully selected as "Science and Technology Innovation Action Plan - Shanghai-Singapore Industrial Innovation Cooperation Project".

Zhou Wei also said that in 2022, XNode Will help more high-quality Singaporean technology start-ups to bring the latest technology to the Chinese market, seek cooperation with Shanghai enterprises, and strive to help more than 45 Singaporean technology innovation enterprises explore Shanghai and the Yangtze River Delta every year. On the other hand, the company will vigorously promote the plan of Chinese technology enterprises to go overseas in 2022, with the support of the Singapore Government and Enterprise Singapore, etc., to accelerate the success of two or more Shanghai technology companies in Southeast Asia on average every year.